Titan Pharma Stock (NASDAQ: TTNP) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 42.000 / 12.309K |
Day Range | - - - |
52 Wk Range | 5.000 - 16.902 |
Market Cap | $5.652M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 48 |
Short Interest | - |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Titan Pharma (NASDAQ: TTNP) through any online brokerage.
Other companies in Titan Pharma’s space includes: Cingulate (NASDAQ:CING), Cocrystal Pharma (NASDAQ:COCP), Kiora Pharmaceuticals (NASDAQ:KPRX), Universe Pharmaceuticals (NASDAQ:UPC) and Jaguar Health (NASDAQ:JAGX).
The latest price target for Titan Pharma (NASDAQ: TTNP) was reported by Maxim Group on Thursday, May 26, 2022. The analyst firm set a price target for 0.00 expecting TTNP to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
The stock price for Titan Pharma (NASDAQ: TTNP) is $7 last updated March 27, 2024 at 5:17 PM EDT.
A quarterly cash dividend of $0.00 per share of Class A Common Stock. The quarterly cash dividend was payable on Invalid DateTime to stockholders of record on December 20, 2001.
Titan Pharma’s Q1 earnings are confirmed for Monday, May 13, 2024.
There is no upcoming split for Titan Pharma.
Titan Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.